Laboratoire Benewmedical is a distributor of innovative medical and surgical devices with high medical and economic added value. Specialized at the outset solely in trading, the company started its shift to manufacturing with a bold and avant-garde positioning in innovative surgical technologies, more particularly in the field of regenerative surgery.
The company sources and negotiates distribution contracts; consequently it is responsible for the market release of the product for which it has a distribution contract, as well as for its quality and safety. With a range of approximately 800 product references, the company operates in three distinct product divisions: regenerative surgery, general surgery and the community healthcare sector.
Context of the deal
In 2023, Axio completed an MBO with Laboratoire Benewmedical. The founder and main shareholder wanted to sell all his shares and arrange a transfer to his two main managers Jérémy Glardon and Damien Bordier. Following this transaction, Axio Capital is a 67.5% shareholder alongside the two managers. The company has great growth potential on the French and export markets, The ambition of this restructured company is to brand itself as a truly specialized manufacturer in the field of regenerative surgery.
Key figures
more than 800
product references
3
product divisions
25
staff
more than 50 %
of sales generated in regenerative surgery